🏢БізнесFDA mandates label updates for popular weight-loss drugs over potential vision risks
The US FDA is requiring updates to warnings for GLP-1 receptor agonists due to a potential link to a rare eye condition.
🏢БізнесThe US FDA is requiring updates to warnings for GLP-1 receptor agonists due to a potential link to a rare eye condition.
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.